Elevate Uranium Ltd

Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. The company's principal projects include the Koppies, Hirabeb, Marenica, and Namib IV in Namibia. It also holds 100% interests in the Angela, Thatcher Soak, Oobagooma, and Minerva project areas, as well as the Bigrlyi, Malawiri, Walbiri, and Areva joint ventures in Australia. The company was formerly known as Marenica Energy Limited and changed its name to Elevate Uranium Ltd in May 2021. Elevate Uranium Ltd was incorporated in 1978 and is headquartered in West Perth, Australia.

Elevate Uranium Ltd trades as ELVUF on OTC. The company is classified in Energy / Uranium and reports in USD.

The current profile places the business in Uranium. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $768,498 of revenue and -$12.32M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Elevate Uranium Ltd can be compared against peers such as Condor Energies Inc., Capricorn Energy PLC, Ferrellgas Partners, L.P., F3 Uranium Corp., GoviEx Uranium Inc., Mega Uranium Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $66.41M, beta of 0.98, and return on equity of -51.6%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

ELVUF currently shows total debt of $432,408 and beta of 0.98. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.elevateuranium.com.au

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.